FIELD: pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics and can be used for treating cancer. Pharmaceutical combination for preventing or treating cancer contains as active ingredients: (a) lipopeptides and poly (I:C) and (b) at least one agent selected from the group consisting of an immune checkpoint inhibitor, a TLR (toll-like receptor) ligand and a saponin. Immune checkpoint inhibitor is at least one selected from a group consisting of an anti-CTLA antibody and an anti-PD-1 antibody. TLR (toll-like receptor) ligand is TLR7 and the saponin is QS-21.
EFFECT: disclosed combination has a strong therapeutic effect on various forms of carcinomas and can be effectively used for anticancer therapy due to significant improvement of anticancer effects.
8 cl, 11 dwg, 1 tbl, 7 ex
| Title |
Year |
Author |
Number |
| MEDICINAL PRODUCT |
2017 |
- Miyakawa, Tomoya
- Doi, Shun
- Tamada, Koji
|
RU2759728C2 |
| MEDICAMENT |
2016 |
- Tamada, Koji
- Doi, Shun
- Miyakawa, Tomoya
|
RU2709015C2 |
| INDUCTION OF APOPTOSIS IN TUMOUR CELLS, EXPRESSING TOLL-LIKE RECEPTOR |
2005 |
- Lebek Serzh
- Renno Tufik
- Salon Brjuno
- Kost-Invernitstsi Izabel'
- Rissoan Mari-Klotil'D
|
RU2401661C9 |
| MULTIDOMAIN VESICLE COMPRISING AN IMMUNOSTIMULATING MATERIAL, A METHOD FOR PRODUCTION THEREOF AND AN IMMUNOMODULATING COMPOSITION THEREOF |
2018 |
|
RU2736639C1 |
| MULTIDOMAIN VESICLE COMPRISING A MATERIAL WHICH CONTROLS AN IMMUNOSUPPRESSIVE FACTOR, A METHOD FOR PRODUCTION THEREOF AND AN IMMUNOMODULATING COMPOSITION THEREOF |
2018 |
|
RU2733124C1 |
| COMBINATION OF AN IMMUNE CHECKPOINT MODULATOR AND A COMPLEX CONTAINING A CELL-PENETRATING PEPTIDE, A CARGO MOLECULE, AND A TLR PEPTIDE AGONIST, FOR APPLICATION IN MEDICINE |
2017 |
- Derouazi Madiha
- Belnoue Elodie
|
RU2769314C1 |
| COMBINATION OF IMMUNE CHECKPOINT MODULATOR AND COMPLEX CONTAINING CELL-PENETRATING PEPTIDE, CARGO MOLECULE, AND TLR PEPTIDE AGONIST FOR MEDICAL USE |
2017 |
- Deruazi Madikha
- Belnu Elodi
|
RU2748378C2 |
| ANTICANCER VACCINE COMPOSITION CONTAINING WT1 PEPTIDE FOR TRANSDERMAL ADMINISTRATION |
2014 |
- Okubo Katsuyuki
- Maeda Josiki
- Okadzaki Arimiti
- Asari Dajsuke
- Sisido Takuya
- Khori Mitsukhiko
- Sugiyama Kharuo
|
RU2687144C2 |
| TLR3 LIGANDS WHICH ACTIVATE BOTH EPITHELIAL AND MYELOID CELLS |
2019 |
- Bonnin, Marc
- Thierry, Sylvain
|
RU2826262C2 |
| IMMUNOSTIMULATING G,U-CONTAINING OLYGORIBONUCLEOTIDES |
2003 |
- Lipford Grehjson B.
- Bauer Shtefan
- Vagner Khermann
|
RU2302865C2 |
